Aligning Institutional Policy With System Updates: A Practical Guide
Aligning Institutional Policy With System Updates: A Practical Guide Keep institutional policies, research administration workflows, and technology aligned as your
CRO
Understanding the Basics of Study Design
A promising research question can still produce inconclusive results if the population, intervention, comparator, endpoints, and analysis approach don’t fit
Why Do Clinical Trial Startup Delays Still Happen Despite More Technology?
Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and research sites still face persistent
London Innovation Summit: Let your network know you’ll be there!
Heading to the Advarra Innovation Summit in London? Share the news and encourage your peers and partners to join you!
When Do Clinical Trials of mRNA Products Fall Under IBC Review
Discover how AI and analytics are transforming clinical trial operations, from study startup to accrual workflows, in this insightful whitepaper.
Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research
In this webinar, leaders from cancer centers and biopharma companies will discuss the operational and institutional hurdles sites face and what can be done to address them. The panel will explore practical strategies to reduce burden, improve collaboration, and create a better experience for research staff and patients alike.
Advarra Innovation Summit San Francisco 2025
Advarra Innovation Summit: San Francisco Join us in San Francisco to explore how sites, sponsors, and CROs can better work
Live Demo: Introducing Site-Facing SSU Milestone Tracking
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.
Improving Clinical Tech Adoption: Site-Centric Approaches
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.
Advarra’s Perspective on FDA’s Draft AI Guidance: Advancing Responsible Innovation
The U.S. Food and Drug Administration’s (FDA’s) recent draft guidance, “Considerations for the Use of Artificial Intelligence to Support Regulatory
From Ethics to Evidence: Applying Real-World Data in Oncology Trials
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.
Consulting GxP services
GxP Compliance Intelligence Global GxP Experts, Smarter with AI From early discovery to managing a global development portfolio, our industry-leading